Abstract
Objective: Acute mesenteric ischemia (AMI) is a potentially life-threatening medical condition that results in bowel infarction and gangrene. It usually occurs over the age of 60 and is seen in both sexes at similar rates. Early diagnosis and treatment are the cornerstones in the treatment of AMI. Although different biochemical markers for AMI are used clinically, no specific laboratory test has been proven to identify the presence of ischemic or necrotic bowel. In this study, we aimed to evaluate Neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLT/LYM), NLR/PLT, mean platelet volume-PLT ratio (MPV)/PLT, and MPV*NLR/PLT could be a useful tool for early prediction of the severity of AMI.
Method: We analyzed retrospectively records of 105 patients diagnosed with acute AMI who were operated on at our clinic. We investigated patient demographics, clinical symptoms, concomitant diseases, blood test results, and data regarding the surgical procedure performed and the resection's width. The patients were divided into two groups as short bowel syndrome (SBS) developing and non-developing.
Results: We enrolled a total of 105 AMI patients in this study. There was no significant difference between the rates of non-SBS and SBS in terms of age, gender, diabetes mellitus, and smoking status. WBC, NEU, LYM, and MPV were higher, and PLT was lower in the SBS group. There were no statistically significant differences in MPV/PLT between the two groups. The combined values of NLR, PLT, and MPV were also compared between non-SBS and SBS groups. According to our results, the means of NLR, PLT/LYM, NLR/PLT, MPV/NLR, and MPV*NLR/PLT variables were statistically significantly different between the two groups.
Conclusions: Our findings showed that NLR, NLR/PLT, MPV/PLT, MPV*NLR, and MPV*NLR/PLT could be a relatively better tool for early prediction of the severity of AMI and SBS. Further studies have to be carried out to investigate the best parameter for predicting the severity or prognosis of AMI.